Table of Contents Author Guidelines Submit a Manuscript
Journal of Addiction
Volume 2015, Article ID 197652, 10 pages
http://dx.doi.org/10.1155/2015/197652
Research Article

Comorbid Psychopathology and Alcohol Use Patterns among Methadone Maintenance Treatment Patients

1Psychiatric Department, “Sotiria” General Hospital of Chest Disease, Mesogeion 152, 11527 Athens, Greece
2Organization against Drugs (OKANA), Mesogeion 152, 11527 Athens, Greece
3Department of Psychiatry, Athens University Medical School, Vas. Sofias 72-74, 11528 Athens, Greece

Received 30 December 2014; Revised 27 February 2015; Accepted 8 March 2015

Academic Editor: Gallus Bischof

Copyright © 2015 Georgios Moussas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. European Monitoring Center for Drugs and Addiction (EMCDDA), Annual Report 2012: The State of the Drugs and Alcohol Problem in Greece, 2013.
  2. European Monitoring Center for Drugs and Addiction (EMCDDA), Annual Report 2011: The State of the Drugs and Alcohol Problem in Greece, 2011.
  3. University Mental Health Research Institute, European School Survey Project on Alcohol and other Drugs (ESPAD) 2011, UMHRI, Athens, Greece, 2012.
  4. University Mental Health Research Institute (UMHRI), 2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point, New Development, Trends and In-Depth Information on Selected Issues, University Mental Health Research Institute, Athens, Greece, 2011.
  5. University Mental Health Research Institute (UMHRI), Annual Report 2013: The State of the Drugs and Alcohol Problem in Greece, Athens, University Mental Health Research Institute (UMHRI), 2014.
  6. Organization against drugs, Report on the 2010-2012 activities.
  7. D. A. Regier, M. E. Farmer, D. S. Rae et al., “Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) Study,” The Journal of the American Medical Association, vol. 264, no. 19, pp. 2511–2518, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. B. J. Rounsaville, H. R. Kranzler, S. Ball, H. Tennen, J. Poling, and E. Triffleman, “Personality disorders in substance abusers: relation to substance use,” Journal of Nervous and Mental Disease, vol. 186, no. 2, pp. 87–95, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. B. F. Grant, F. S. Stinson, D. A. Dawson et al., “Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions,” Archives of General Psychiatry, vol. 61, no. 8, pp. 807–816, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. K. Brooner, V. L. King, M. Kidorf, C. W. Schmidt, and G. E. Bigelow, “Psychiatric and substance use comorbidity among treatment-seeking opioid abusers,” Archives of General Psychiatry, vol. 54, no. 1, pp. 71–80, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Maremmani, P. P. Pani, A. Mellini et al., “Alcohol and cocaine use and abuse among opioid addicts engaged in a Methadone Maintenance Treatment Program,” Journal of Addictive Diseases, vol. 26, no. 1, pp. 61–70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. G. Fulton, S. P. Barrett, C. MacIsaac, and S. H. Stewart, “The relationship between self-reported substance use and psychiatric symptoms in low-threshold methadone maintenance treatment clients,” Harm Reduction Journal, vol. 8, article 18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kokkevi and C. Stefanis, “Drug abuse and psychiatric comorbidity,” Comprehensive Psychiatry, vol. 36, no. 5, pp. 329–337, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Ross, M. Teesson, S. Darke et al., “The characteristics of heroin users entering treatment: Findings from the Australian treatment outcome study (ATOS),” Drug and Alcohol Review, vol. 24, no. 5, pp. 411–418, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Hassel, T. Nordfjærn, and R. Hagen, “Psychological and interpersonal distress among patients with substance use disorders: are these factors associated with continued drug use and do they change during treatment?” Journal of Substance Use, vol. 18, no. 5, pp. 363–376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. K. Roszell, D. A. Calsyn, and E. F. Chaney, “Alcohol use and psychopathology in opioid addicts on methadone maintenance,” The American Journal of Drug and Alcohol Abuse, vol. 12, no. 3, pp. 269–278, 1986. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Bleich, M. Gelkopf, V. Schmidt, R. Hayward, G. Bodner, and M. Adelson, “Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic,” Addiction, vol. 94, no. 10, pp. 1533–1540, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Dobler-Mikola, J. Hättenschwiler, D. Meili, T. Beck, E. Böni, and J. Modestin, “Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment,” Journal of Substance Abuse Treatment, vol. 29, no. 4, pp. 259–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Brands, J. Blake, B. Sproule, D. Gourlay, and U. Busto, “Prescription opioid abuse in patients presenting for methadone maintenance treatment,” Drug and Alcohol Dependence, vol. 73, no. 2, pp. 199–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Laqueille, C. Launay, A. Dervaux, and M. Kanit, “Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature,” Encephale, vol. 35, no. 3, pp. 220–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. J. Mason, J. H. Kocsis, D. Melia et al., “Psychiatric comorbidity in methadone maintained patients,” Journal of Addictive Diseases, vol. 17, no. 3, pp. 75–89, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Maremmani, O. Zolesi, M. Aglietti, G. Marini, A. Tagliamonte, and S. Maxwell, “Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity,” Journal of Addictive Diseases, vol. 19, no. 2, pp. 29–41, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. E. C. Strain, G. E. Bigelow, I. A. Liebson, and M. L. Stitzer, “Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial,” The Journal of the American Medical Association, vol. 281, no. 11, pp. 1000–1005, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Parvaresh, A. Masoudi, S. Majidi-Tabrizi, and S. Mazhari, “The correlation between methadone dosage and comorbid psychiatric disorders in patients on methadone maintenance treatment,” Addiction & Health, vol. 4, no. 1-2, pp. 1–8, 2012. View at Google Scholar
  25. M. Gelkopf, T. Weizman, Y. Melamed, M. Adelson, and A. Bleich, “Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic,” Israel Journal of Psychiatry and Related Sciences, vol. 43, no. 2, pp. 126–136, 2006. View at Google Scholar · View at Scopus
  26. P. J. Carpentier, P. F. M. Krabbe, M. T. van Gogh, L. J. M. Knapen, J. K. Buitelaar, and C. A. J. de Jong, “Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients,” American Journal on Addictions, vol. 18, no. 6, pp. 470–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Astals, A. Domingo-Salvany, C. C. Buenaventura et al., “Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment,” Substance Use and Misuse, vol. 43, no. 5, pp. 612–632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. Y.-Z. Chen, W.-L. Huang, J.-C. Shan, Y.-H. Lin, H.-C. W. Chang, and L.-R. Chang, “Self-reported psychopathology and health-related quality of life in heroin users treated with methadone,” Neuropsychiatric Disease and Treatment, vol. 9, no. 1, pp. 41–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Karow, U. Verthein, R. Pukrop et al., “Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence,” Substance Use and Misuse, vol. 46, no. 6, pp. 705–715, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J. P. Feelemyer, D. C. D. Jarlais, K. Arasteh, B. W. Phillips, and H. Hagan, “Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review,” Drug and Alcohol Dependence, vol. 134, no. 1, pp. 251–258, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. T. McLellan, L. Luborsky, G. E. Woody, C. P. O'Brien, and K. A. Druley, “Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity,” Archives of General Psychiatry, vol. 40, no. 6, pp. 620–625, 1983. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Darke, “The effectiveness of methadone maintenance treatment 3: moderators of treatment outcome,” in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, J. Ward, R. P. Mattick, and W. Hall, Eds., pp. 75–89, Harwood Academic Publishers, Amsterdam, The Netherlands, 1998. View at Google Scholar
  33. A. T. McLellan, A. R. Childress, J. Griffith, and G. E. Woody, “The psychiatrically severe drug abuse patient: methadone maintenance or therapeutic community?” The American Journal of Drug and Alcohol Abuse, vol. 10, no. 1, pp. 77–95, 1984. View at Publisher · View at Google Scholar · View at Scopus
  34. B. J. Rounsaville, T. R. Kosten, M. M. Weissman, and H. D. Kleber, “Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study,” Archives of General Psychiatry, vol. 43, no. 8, pp. 739–745, 1986. View at Publisher · View at Google Scholar · View at Scopus
  35. J. S. Cacciola, A. I. Alterman, M. J. Rutherford, J. R. McKay, and F. D. Mulvaney, “The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients,” Drug and Alcohol Dependence, vol. 61, no. 3, pp. 271–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. G. E. Woody, A. T. McLellan, L. Luborsky et al., “Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn study,” American Journal of Psychiatry, vol. 141, no. 10, pp. 1172–1177, 1984. View at Publisher · View at Google Scholar · View at Scopus
  37. U. Verthein, P. Degkwitz, C. Haasen, and M. Krausz, “Significance of comorbidity for the long-term course of opiate dependence,” European Addiction Research, vol. 11, no. 1, pp. 15–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. P. P. Pani, E. Trogu, P. Contu, A. Agus, and G. L. Gessa, “Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program,” Drug and Alcohol Dependence, vol. 48, no. 2, pp. 119–126, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. P. P. Pani, I. Maremmani, M. Pacini, F. Lamanna, A. G. I. Maremmani, and L. Dell'Osso, “Effect of psychiatric severity on the outcome of methadone maintenance treatment,” European Addiction Research, vol. 17, no. 2, pp. 80–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Astals, L. Díaz, A. Domingo-Salvany, R. Martín-Santos, A. Bulbena, and M. Torrens, “Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study,” International Journal of Environmental Research and Public Health, vol. 6, no. 11, pp. 2822–2832, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Schäfer, M. Fischer, J. Reimer, A. Karow, and C. Haasen, “Significance of psychiatric comorbidity for the outcome of maintenance treatment—a review of the literature,” Mental Health and Substance Use, vol. 4, no. 1, pp. 62–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. H.-Y. Lee, J.-H. Li, Y.-L. Sheu et al., “Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan,” BioMed Research International, vol. 2013, Article ID 741403, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. G. C. Urbaniak and S. Plous, Research Randomizer (Version 4.0), Computer software, 2013, http://www.randomizer.org/.
  44. L. R. Derogatis, R. S. Lipman, and L. Covi, “SCL-90: an outpatient psychiatric rating scale—preliminary report,” Psychopharmacology Bulletin, vol. 9, no. 1, pp. 13–28, 1973. View at Google Scholar · View at Scopus
  45. L. R. Derogatis, Symptom Checklist-90-R Administration, Scoring and Procedures Manual II, Clinical Psychometric Research, Towson, Md, USA, 1983.
  46. L. R. Derogatis, Handbook of Psychiatric Measures, American Psychiatric Association, Arlington, Va, USA, 2000.
  47. G. Vitoratou, Standardization and analysis of psychometric characteristics of recruit reserve officers [M.S. thesis], Department of Mathematics, University of Athens Medical School, Athens, Greece, 2004, (Greek).
  48. K. Giotakis, A. Douzenis, A. Tselebis et al., “Psychological parameters and habitual smoking among health professionals,” Encephalos, vol. 50, no. 3, pp. 82–88, 2013. View at Google Scholar
  49. A. Tselebis, D. Bratis, E. Kosmas et al., “Psychological symptom patterns and vital exhaustion in outpatients with chronic obstructive pulmonary disease,” Annals of General Psychiatry, vol. 10, article 32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Tselebis, E. Kosmas, D. Bratis et al., “Contribution of psychological factors in dropping out from chronic obstructive pulmonary disease rehabilitation programs,” BioMed Research International, vol. 2014, Article ID 401326, 6 pages, 2014. View at Publisher · View at Google Scholar
  51. S. Donias, A. Karastergiou, and N. Manos, “Standardization of the symptom checklist-90-R rating scale in a Greek population,” Psychiatriki, vol. 2, no. 1, pp. 42–48, 1991 (Greek). View at Google Scholar
  52. H. E. Klugh, “Normalized T scores,” in Encyclopedia of Statistical Sciences, S. Kotz, C. B. Read, N. Balakrishnan, and B. Vidakovic, Eds., John Wiley & Sons, New York, NY, USA, 2nd edition, 2006. View at Google Scholar
  53. W. A. McCall, How to Measure in Education, Macmillan, New York, NY, USA, 1922.
  54. J. B. Saunders, O. G. Aasland, T. F. Babor, J. R. de la Fuente, and M. Grant, “Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II,” Addiction, vol. 88, no. 6, pp. 791–804, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. T. F. Babor, J. C. Higgins-Biddle, J. B. Saunders et al., AUDIT—The Alcohol Use Disorder Identification Test: Guidelines for Use in Primary Health Care, Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland, 2nd edition, 2001.
  56. G. Moussas, G. Dadouti, A. Douzenis et al., “Reliability and validity of the Greek version of the alcohol use disorders identification test (AUDIT),” Psychiatriki, vol. 21, no. 1, pp. 54–59, 2010. View at Google Scholar
  57. G. Moussas, G. Dadouti, A. Douzenis et al., “The Alcohol Use Disorders Identification Test (AUDIT): reliability and validity of the Greek version,” Annals of General Psychiatry, vol. 8, article 11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. P. E. Jacobs, E. B. Doft, and J. Koger, “A study of SCL-90 scores of 264 methadone patients in treatment,” International Journal of the Addictions, vol. 16, no. 3, pp. 541–548, 1981. View at Google Scholar · View at Scopus
  59. P. P. Pani, E. Trogu, F. Vigna-Taglianti et al., “Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment,” Annals of General Psychiatry, vol. 13, article 35, 2014. View at Publisher · View at Google Scholar
  60. L. R. Chatham, M. L. Hiller, G. A. Rowan-Szal, G. W. Joe, and D. D. Simpson, “Gender differences at admission and follow-up in a sample of methadone maintenance clients,” Substance Use and Misuse, vol. 34, no. 8, pp. 1137–1165, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. F. J. Eiroá-Orosa, U. Verthein, S. Kuhn et al., “Implication of gender differences in heroin-assisted treatment: results from the German randomized controlled trial,” The American Journal on Addictions, vol. 19, no. 4, pp. 312–318, 2010. View at Publisher · View at Google Scholar
  62. M. Bawor, B. B. Dennis, R. Anglin, M. Steiner, L. Thabane, and Z. Samaan, “Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol,” Systematic Reviews, vol. 3, article 45, 2014. View at Google Scholar
  63. I. Maremmani, P. P. Pani, M. Pacini et al., “Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90),” Annals of General Psychiatry, vol. 9, article 15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Joseph, S. Stancliff, and J. Langrod, “Methadone maintenance treatment (MMT): A review of historical and clinical issues,” The Mount Sinai Journal of Medicine, vol. 67, no. 5-6, pp. 347–364, 2000. View at Google Scholar · View at Scopus
  65. G. T. Ray, J. R. Mertens, and C. Weisner, “Family members of people with alcohol or drug dependence: health problems and medical cost compared to family members of people with diabetes and asthma,” Addiction, vol. 104, no. 2, pp. 203–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Simpson, “National treatment system evaluation based on the drug abuse reporting program (DARP) follow-up research,” in Drug Abuse Treatment Evaluation: Strategies, Progress and Prospects, F. M. Tims and J. P. Ludford, Eds., vol. 51, pp. 66–79, National lnstitute on Drug Abuse Research Monograph, Rockville, Md, USA, 1984. View at Google Scholar
  67. A. Paraherakis, Substance-related disorders and associated psychopathology: predicting addictions treatment outcome [M.S. thesis], Faculty of Graduate Studies and Research, McGill University, Montréal, Canada, 1997.
  68. S. M. Y. Ardakani, S. Banaei-Boroujeni, and G. Dastjerdi, “Psychiatric disorders prevalence comparison in opiate-dependent and non-opiate dependent individuals,” Journal of Addiction Research & Therapy, no. S8, article 5, 2013. View at Publisher · View at Google Scholar
  69. B. S. McCrady, “To have but one true friend: Implications for practice of research on alcohol use disorders and social networks,” Psychology of Addictive Behaviors, vol. 18, no. 2, pp. 113–121, 2004. View at Google Scholar · View at Scopus
  70. J. M. O'neill, J. K. Clark, and J. A. Jones, “Promoting mental health and preventing substance abuse and violence in elementary students: a randomized control study of the michigan model for health,” Journal of School Health, vol. 81, no. 6, pp. 320–330, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Kiss, B. Pikó, and A. Vetró, “Frequency of smoking, drinking, and substance use and their relationship to psychiatric comorbidity in depressed child and adolescent population,” Psychiatria Hungarica, vol. 21, no. 5, pp. 371–378, 2006. View at Google Scholar · View at Scopus
  72. U. Frischknecht, B. Beckmann, M. Heinrich et al., “The vicious circle of perceived stigmatization, depressiveness, anxiety, and low quality of life in substituted heroin addicts,” European Addiction Research, vol. 17, no. 5, pp. 241–249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. C.-N. Yen, C. S.-M. Wang, T.-Y. Wang, H.-F. Chen, and H.-C. Chang, “Quality of life and its correlates among heroin users in Taiwan,” Kaohsiung Journal of Medical Sciences, vol. 27, no. 5, pp. 177–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. H. S. Esfandabada, S. Nejadnaderi, and S. Emamipour, “Assessment of quality of life and psychological disorder symptoms among opium—dependent men on buprenorphine detoxification,” Procedia—Social and Behavioral Sciences, vol. 5, pp. 1396–1399, 2010. View at Google Scholar
  75. I. Maremmani, P. P. Pani, A. G. I. Maremmani et al., “Psychopathological symptoms of heroin addicts at treatment entry,” Heroin Addiction and Related Clinical Problems, vol. 15, no. 2, pp. 37–46, 2013. View at Google Scholar · View at Scopus
  76. P. P. Pani, “Addiction: challenging the dual diagnosis construct,” Heroin Addiction and Related Clinical Problems, vol. 12, no. 2, pp. 5–8, 2010. View at Google Scholar · View at Scopus
  77. P. P. Pani, I. Maremmani, E. Trogu, G. L. Gessa, P. Ruiz, and H. S. Akiskal, “Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included?” Journal of Affective Disorders, vol. 122, no. 3, pp. 185–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. N. El-Bassel, R. F. Schilling, J. E. Turnbull, and K.-H. Su, “Correlates of alcohol use among methadone patients,” Alcoholism: Clinical and Experimental Research, vol. 17, no. 3, pp. 681–686, 1993. View at Publisher · View at Google Scholar · View at Scopus
  79. S. G. Craddock, J. L. Rounds-Bryant, P. M. Flynn, and R. L. Hubbard, “Characteristics and pre-treatment behaviors of clients entering drug abuse treatment: 1969 to 1993,” The American Journal of Drug and Alcohol Abuse, vol. 23, no. 1, pp. 43–59, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Rittmannsberger, C. Silberbauer, R. Lehner, and M. Ruschak, “Alcohol consumption during methadone maintenance treatment,” European Addiction Research, vol. 6, no. 1, pp. 2–7, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. H. Joseph and P. Appel, “Alcoholism and methadone treatment: consequences for the patient and program,” The American Journal of Drug and Alcohol Abuse, vol. 11, no. 1-2, pp. 37–53, 1985. View at Publisher · View at Google Scholar · View at Scopus
  82. I.-C. Chen, W.-C. Chie, H.-G. Hwu et al., “Alcohol use problem among patients in methadone maintenance treatment in Taiwan,” Journal of Substance Abuse Treatment, vol. 40, no. 2, pp. 142–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. K. Witkiewitz, “Predictors of heavy drinking during and following treatment,” Psychology of Addictive Behaviors, vol. 25, no. 3, pp. 426–438, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. D. D. Brewer, R. F. Catalano, K. Haggerty, R. R. Gainey, and C. B. Fleming, “A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction,” Addiction, vol. 93, no. 1, pp. 73–92, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Stenbacka, O. Beck, A. Leifman, A. Romelsjö, and A. Helander, “Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment,” Drug and Alcohol Review, vol. 26, no. 1, pp. 55–63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. I. Siassi and D. C. Alston, “Methadone maintenance and the problem with alcohol,” The American Journal of Drug and Alcohol Abuse, vol. 3, no. 2, pp. 267–277, 1976. View at Publisher · View at Google Scholar · View at Scopus
  87. D. Teplin, B. Raz, J. Daiter, M. Varenbut, and C. Plater-Zyberk, “Screening for alcohol use patterns among methadone maintenance patients,” American Journal of Drug and Alcohol Abuse, vol. 33, no. 1, pp. 179–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Hillebrand, J. Marsden, E. Finch, and J. Strang, “Excessive alcohol consumption and drinking expectations among clients in methadone maintenance,” Journal of Substance Abuse Treatment, vol. 21, no. 3, pp. 155–160, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. L. Öhlin, M. Hesse, M. Fridell, and P. Tätting, “Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile,” BMC Psychiatry, vol. 11, article 81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. M. J. Rutherford, J. S. Cacciola, and A. I. Alterman, “Relationships of personality disorders with problem severity in methadone patients,” Drug and Alcohol Dependence, vol. 35, no. 1, pp. 69–76, 1994. View at Publisher · View at Google Scholar · View at Scopus
  91. S. A. Ball, “Comparing individual therapies for personality disordered opioid dependent patients,” Journal of Personality Disorders, vol. 21, no. 3, pp. 305–321, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. L. E. Wüsthoff, H. Waal, and R. W. Gråwe, “The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression—a group randomized trial,” BMC Psychiatry, vol. 14, no. 1, article 67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Nalaskowska and L. Cierpiałkowska, “Social and psychological functioning of opiate dependent patients in methadone maintenance treatment—longitudinal research report,” Alcoholism and Drug Addiction, vol. 27, no. 3, pp. 237–254, 2014. View at Publisher · View at Google Scholar
  94. E. Wu, N. El-Bassel, L. Gilbert, M. Chang, and G. Sanders, “Effects of receiving additional off-site services on abstinence from illicit drug use among men on methadone: a longitudinal study,” Evaluation and Program Planning, vol. 33, no. 4, pp. 403–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. A. T. McLellan, I. O. Arndt, D. S. Metzger, G. E. Woody, and C. P. O'Brien, “The effects of psychosocial services in substance abuse treatment,” Journal of the American Medical Association, vol. 269, no. 15, pp. 1953–1959, 1993. View at Publisher · View at Google Scholar · View at Scopus
  96. L. Goehl, E. Nunes, F. Quitkin, and I. Hilton, “Social networks and methadone treatment outcome: the costs and benefits of social ties,” The American Journal of Drug and Alcohol Abuse, vol. 19, no. 3, pp. 251–262, 1993. View at Publisher · View at Google Scholar · View at Scopus
  97. T. Nordfjærn, R. Hole, and T. Rundmo, “Interrelations between patients' personal life events, psychosocial distress, and substance use,” Substance Use & Misuse, vol. 45, no. 7-8, pp. 1161–1179, 2010. View at Publisher · View at Google Scholar · View at Scopus